User profiles for "author:Tai-Chung Tseng"
 | Tai-Chung TsengNational Taiwan University Hospital Verified email at ntu.edu.tw Cited by 2826 |
Factors associated with rates of HBsAg seroclearance in adults with chronic HBV infection: a systematic review and meta-analysis
Background & Aims Seroclearance of hepatitis B surface antigen (HBsAg) is a marker for
clearance of chronic hepatitis B virus (HBV) infection, but reported annual incidence rates of …
clearance of chronic hepatitis B virus (HBV) infection, but reported annual incidence rates of …
[HTML][HTML] Clinical utility of quantitative HBsAg in natural history and nucleos (t) ide analogue treatment of chronic hepatitis B: new trick of old dog
Using commercial quantitative assays, quantitative hepatitis B surface antigen (qHBsAg) has
improved our understanding and management of chronic hepatitis B (CHB). The HBsAg …
improved our understanding and management of chronic hepatitis B (CHB). The HBsAg …
Hepatitis B virus infection and metabolic syndrome: fact or fiction?
CC Wang, TC Tseng, JH Kao - Journal of gastroenterology and …, 2015 - Wiley Online Library
Although hepatitis C virus infection is known to be linked with insulin resistance,
dyslipidemia, and hepatic steatosis, the relationship between hepatitis B virus (HBV) …
dyslipidemia, and hepatic steatosis, the relationship between hepatitis B virus (HBV) …
High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load
BACKGROUND & AIMS: Patients with chronic hepatitis B virus (HBV) infection have a high
risk for developing hepatocellular carcinoma (HCC). Patients with lower levels of hepatitis B …
risk for developing hepatocellular carcinoma (HCC). Patients with lower levels of hepatitis B …
[PDF][PDF] Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads
Chronic hepatitis B patients with high viral loads are at increased risk of cirrhosis and
hepatocellular carcinoma (HCC). In patients with low viral loads, higher hepatitis B surface …
hepatocellular carcinoma (HCC). In patients with low viral loads, higher hepatitis B surface …
[PDF][PDF] Determinants of spontaneous surface antigen loss in hepatitis B e antigen–negative patients with a low viral load
Loss of hepatitis B surface antigen (HBsAg) usually indicates the cure of hepatitis B virus
(HBV) infection. In spontaneous hepatitis B e antigen (HBeAg) seroconverters, lower serum …
(HBV) infection. In spontaneous hepatitis B e antigen (HBeAg) seroconverters, lower serum …
Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters
BACKGROUND & AIMS: Loss of hepatitis B surface antigen (HBsAg) usually indicates that
hepatitis B virus (HBV) infection has been cured. However, little is known about factors …
hepatitis B virus (HBV) infection has been cured. However, little is known about factors …
High level of hepatitis B core–related antigen associated with increased risk of hepatocellular carcinoma in patients with chronic HBV infection of intermediate viral …
Background & Aims Chronic hepatitis B virus (HBV) infection is a risk factor for
hepatocellular carcinoma (HCC). Serum levels of HB core–related antigen (HBcrAg) have …
hepatocellular carcinoma (HCC). Serum levels of HB core–related antigen (HBcrAg) have …
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
CH Liu, CJ Liu, CL Lin, CC Liang, SJ Hsu… - Clinical infectious …, 2008 - academic.oup.com
Background. Comparable sustained virologic response (SVR) rates have been documented
between Asian patients who received 24 weeks of pegylated interferon (IFN) plus ribavirin …
between Asian patients who received 24 weeks of pegylated interferon (IFN) plus ribavirin …
Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
Abstract Background & Aims Oral antiviral therapy may reduce the disease progression of
chronic hepatitis B (CHB) patients. We aimed to further investigate the efficacy of long‐term …
chronic hepatitis B (CHB) patients. We aimed to further investigate the efficacy of long‐term …